About VeraSci
VeraSci is a Healthcare company based in Durham (United States) founded in 2016, and was acquired by WIRB-Copernicus Group in July 2021. Provider of data management and site selection services. VeraSci offers products and services including IRB Review, eCOA/ePRO Platform, and Site Enablement. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Functional Services. Its competitors include SSI Strategy, Health Decisions and Antios Therapeutics; 1 of its 3 listed competitors has raised funding.
Company details
VeraSci, backed by 1400000.0 from SBIR, focuses on providing healthcare solutions, biopharma outsourcing, cro, clinical development, functional services, and diversified. Provider of data management and site selection services. Driving innovation, growth, and excellence in its industry sectors. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Durham, United States
- Stage Acquired
- SectorsHealthcare
- Website verasci.com
- Social X
- Acquired by WIRB-Copernicus Group (Jul 2021)
- InvestorsWIRB-Copernicus Group
& 1 more
- Acquired byWIRB-Copernicus Group
(Jul 2021)
Products & Services of VeraSci
VeraSci offers a comprehensive portfolio of products and services, including IRB Review, eCOA/ePRO Platform, and Site Enablement.
Provides ethical review for clinical trials and studies
Platform for electronic data collection in clinical trials
Assists with study start-up and resource management
Funding Insights of VeraSci
- Total Rounds 2
- First Round $1.4M
(May 2016)
- Investors Count 1
All 2 funding rounds of VeraSci with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2016 | Grant | – | – | ||
| May 2016 | $1.4M | Grant | – | – | – |
2 investors in total: 2 institutional.
Investors in VeraSci
VeraSci has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include WIRB-Copernicus Group and SBIR.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Federal innovation and scientific achievement services are provided. | 1982 | sbir.gov | Lithia Springs, United States | |
Regulatory and ethical review services for clinical research are provided. | 2012 | wcgclinical.com | Princeton, United States |
Investor details for VeraSci
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of VeraSci
4 dated milestones of VeraSci across 5 years, from founding to its latest funding, stage changes and deals.
- Founded VeraSci is founded.
- Funding First funding round of $1.4M.
- Funding Latest funding round, Grant,.
- Exit Acquired by WIRB-Copernicus Group.
Competitors of VeraSci
VeraSci has 3 listed competitors in our database, 1 of them funded. They include SSI Strategy, Health Decisions and Antios Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ssistrategy.com | 2010 | Parsippany Troy Hills, United States | Pharmacovigilance and medical affairs services are offered for drug development. | |||
| healthdec.com | 1989 | Durham, United States | 110 | CRO focused on clinical trial services for data management, monitoring and biostatistics | ||
| antiostherapeutics.com | 2018 | Atlanta, United States | $200.4M | Innovative therapies for treating and curing viral diseases are developed. |
Detailed competitors of VeraSci
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as VeraSci (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Verasci
Complete news archive for VeraSci
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VeraSci
VeraSci was founded in 2016.
VeraSci is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
VeraSci, backed by 1400000.0 from SBIR, focuses on providing healthcare solutions, biopharma outsourcing, cro, clinical development, functional services, and diversified. Provider of data management and site selection services. Driving innovation, growth, and excellence in its industry sectors. It continues to evolve, meeting industry challenges with strategic approaches.
VeraSci's top competitors include SSI Strategy, Health Decisions and Antios Therapeutics.
VeraSci offers IRB Review, eCOA/ePRO Platform, and Site Enablement.
VeraSci has 2 investors. Key investors include WIRB-Copernicus Group, and SBIR.
Yes. VeraSci was acquired by WIRB-Copernicus Group in July 2021.